KC
ABBV icon

Kepler Cheuvreux’s AbbVie ABBV Stock Holding History

Kepler Cheuvreux’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.5M Buy
208,949
+76,431
+58% +$16.4M 3.01% 5
2026
Q1 		$28.8M Sell
132,518
-4,696
-3% -$1.04M 1.92% 15
2025
Q4 		$31.4M Buy
137,214
+104,651
+321% +$23.8M 1.77% 18
2025
Q3 		$7.54M Buy
+32,563
New +$6.63M 0.41% 71

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Kepler Cheuvreux's ABBV Position: Q2 2026 in Review

Kepler Cheuvreux increased its AbbVie (ABBV) stake by 58% in Q2 2026, buying an estimated $16.4M and bringing the position to 208,949 shares worth $52.5M. The position accounts for 3.01% of the portfolio, ranked #5.

Kepler Cheuvreux first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kepler Cheuvreux held 208,949 shares of AbbVie worth $52.5M as of Q2 2026.
  • Kepler Cheuvreux bought 76,431 AbbVie shares in Q2 2026, an estimated $16.4M.
  • AbbVie made up 3.01% of Kepler Cheuvreux's portfolio in Q2 2026, its #5 holding.
  • Kepler Cheuvreux first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kepler Cheuvreux's 13F filing for Q2 2026, filed 15 Jul 2026.